Melissa Calton

Title: Melissa Calton: Innovator in Pulmonary Delivery Technologies

Introduction

Melissa Calton is a prominent inventor based in Emeryville, CA (US). She has made significant contributions to the field of pulmonary delivery technologies, holding a total of 2 patents. Her work focuses on innovative methods for delivering therapeutic agents to lung cells, which is crucial for treating various pulmonary disorders.

Latest Patents

Among her latest patents is a groundbreaking invention related to adeno-associated variants, formulations, and methods for pulmonary delivery. This patent provides a variant AAV capsid protein that confers tropism to lung cells. It also includes recombinant adeno-associated viruses comprising the variant AAV and pharmaceutical compositions that utilize these innovations for the effective delivery of heterologous nucleic acids to lung cells.

Career Highlights

Melissa Calton is currently associated with 4D Molecular Therapeutics Inc., where she continues to advance her research and development efforts. Her expertise in the field has positioned her as a key player in the development of novel therapeutic strategies aimed at improving patient outcomes in pulmonary health.

Collaborations

Throughout her career, Melissa has collaborated with notable colleagues, including Melissa Kotterman and Peter Francis. These partnerships have fostered a collaborative environment that enhances innovation and drives forward the research initiatives at her company.

Conclusion

Melissa Calton's contributions to pulmonary delivery technologies exemplify her commitment to advancing medical science. Her innovative patents and collaborative efforts are paving the way for new treatments that can significantly impact patient care in respiratory health.